Cannamerica Brands Corp

Healthcare US CNNXF

0.0USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

52 Week Range

LowHigh

Fundamentals

Previous Close -
Market Cap0.00075M
Volume0
P/E Ratio-
Dividend Yield-%
EBITDA-0.82046M
Revenue TTM0.65M
Revenue Per Share TTM0.01
Gross Profit TTM 0.53M
Diluted EPS TTM-0.06

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2021-03-31	2020-03-31	2019-03-31	2018-03-31
Type	yearly	yearly	yearly	yearly
Date	2021-03-31	2020-03-31	2019-03-31	2018-03-31
Income before tax	-3.55096M	-4.63070M	-8.99639M	0.00000M
Minority interest	-	-	-	-
Net income	-3.55096M	-4.63070M	-8.91639M	0.00000M
Selling general administrative	1.29M	3.22M	5.30M	0.00000M
Selling and marketing expenses	-	-	-	-
Gross profit	0.33M	0.78M	0.45M	0.00000M
Reconciled depreciation	0.02M	0.02M	0.00500M	-
Ebit	-0.98483M	-2.42024M	-5.32820M	0.02M
Ebitda	-3.01997M	-4.27312M	-8.86284M	-
Depreciation and amortization	-	-	-	-
Non operating income net other	-	-	-	-
Operating income	-0.98483M	-2.44968M	-4.85033M	0.00000M
Other operating expenses	-	-	-	-
Interest expense	0.51M	0.34M	0.13M	0.00000M
Tax provision	-	0.00000M	-0.08000M	0.00000M
Interest income	-	-	-	-
Net interest income	-0.51404M	-0.34352M	-0.14302M	0.00000M
Extraordinary items	-	-	-	-
Non recurring	-	-	-	-
Other items	-	-	-	-
Income tax expense	-	-	-0.08000M	-
Total revenue	0.39M	0.92M	0.98M	0.00000M
Total operating expenses	1.37M	3.36M	5.83M	0.00000M
Cost of revenue	0.06M	0.13M	0.53M	0.00000M
Total other income expense net	-2.05209M	-1.83750M	-4.00303M	-0.11464M
Discontinued operations	-	-	-	-
Net income from continuing ops	-3.55096M	-4.63070M	-8.91639M	0.00000M
Net income applicable to common shares	-3.55096M	-4.63070M	-8.91639M	-0.09409M
Preferred stock and other adjustments	-	-	-	-

Breakdown	2021-03-31	2020-03-31	2019-03-31	2018-03-31
Type	yearly	yearly	yearly	yearly
Date	2021-03-31	2020-03-31	2019-03-31	2018-03-31
Total assets	0.31M	2.87M	5.96M	0.11M
Intangible assets	0.00000M	1.38M	3.10M	5.67M
Earning assets	-	-	-	-
Other current assets	-	-	-	-
Total liab	5.07M	5.83M	5.21M	0.00000M
Total stockholder equity	-4.76932M	-2.95869M	0.75M	0.11M
Deferred long term liab	-	-	-	-
Other current liab	0.35M	0.29M	0.32M	-
Common stock	9.21M	8.06M	7.87M	0.00000M
Capital stock	9.21M	8.06M	7.87M	-
Retained earnings	-17.09805M	-13.54709M	-8.91639M	-0.09409M
Other liab	-	-	-	-
Good will	-	-	-	-
Other assets	-	-	-	-0.00016M
Cash	0.04M	0.02M	0.75M	0.00000M
Cash and equivalents	-	-	-	-
Total current liabilities	5.07M	5.83M	5.21M	1.23M
Current deferred revenue	-	-	-	-
Net debt	4.39M	4.63M	3.23M	-
Short term debt	-	-	3.98M	0.84M
Short long term debt	4.43M	4.65M	3.98M	0.84M
Short long term debt total	-	-	-	-
Other stockholder equity	0.29M	-0.23199M	-0.12095M	-0.00169M
Property plant equipment	0.06M	0.06M	0.06M	-
Total current assets	0.24M	0.55M	1.86M	0.23M
Long term investments	-	0.89M	0.95M	0.00000M
Net tangible assets	-4.76933M	-4.33369M	-2.35116M	-5.76558M
Short term investments	-	-	-	-
Net receivables	0.06M	0.14M	0.24M	0.23M
Long term debt	-	-	-	4.82M
Inventory	-	-	-	-
Accounts payable	0.27M	0.71M	0.79M	0.35M
Total permanent equity	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-
Accumulated other comprehensive income	-	-	-	-
Additional paid in capital	-	-	-	-
Common stock total equity	-	-	-	-
Preferred stock total equity	-	-	-	-
Retained earnings total equity	-	-	-	-
Treasury stock	-	-	-	-
Accumulated amortization	-	-	-	-
Non currrent assets other	-	-	4.10M	0.00000M
Deferred long term asset charges	-	-	-	-
Non current assets total	0.06M	2.32M	4.10M	-
Capital lease obligations	-	-	-	-
Long term debt total	-	-	-	-

Breakdown	2021-03-31	2020-03-31	2019-03-31	2018-03-31
Type	yearly	yearly	yearly	yearly
Date	2021-03-31	2020-03-31	2019-03-31	2018-03-31
Investments	0.07M	0.07M	0.07M	0.07M
Change to liabilities	-0.02265M	-0.05634M	0.70M	0.08M
Total cashflows from investing activities	0.05M	-0.02065M	0.96M	0.96M
Net borrowings	0.09M	0.09M	-1.82565M	-1.82565M
Total cash from financing activities	0.09M	0.16M	1.22M	1.22M
Change to operating activities	0.25M	0.48M	-0.72429M	-0.03947M
Net income	-3.55096M	-4.63070M	-8.91639M	-0.09409M
Change in cash	0.02M	-0.73225M	0.75M	0.75M
Begin period cash flow	0.02M	0.75M	0.00000M	-
End period cash flow	0.04M	0.02M	0.75M	-
Total cash from operating activities	-0.14142M	-0.82608M	-1.24363M	-0.00037M
Issuance of capital stock	-	0.00000M	3.42M	-
Depreciation	0.02M	0.02M	0.00500M	0.00500M
Other cashflows from investing activities	-	-	-	-
Dividends paid	-	-	-	-
Change to inventory	-	0.00000M	0.15M	0.15M
Change to account receivables	0.08M	0.16M	1.92M	-0.05946M
Sale purchase of stock	-	-	-	-
Other cashflows from financing activities	-	-	-0.37084M	-0.37084M
Change to netincome	3.09M	3.21M	5.61M	0.11M
Capital expenditures	0.02M	0.02M	0.05M	0.05M
Change receivables	-	-	-	-
Cash flows other operating	-	-	-	-
Exchange rate changes	-	-	-	-
Cash and cash equivalents changes	-	-	-	-
Change in working capital	0.30M	0.58M	2.05M	-
Stock based compensation	0.49M	1.01M	1.59M	-
Other non cash items	0.44M	0.34M	0.13M	-
Free cash flow	-0.16397M	-0.84672M	-1.29726M	-

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
CNNXF Cannamerica Brands Corp	- -%	-	-	-	0.0012	-	3.08	-1.0727
ZTS Zoetis Inc	-2.82 3.58%	75.89	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	-0.19 0.62%	30.56	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	157.12	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	- -%	42.94	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

CannAmerica Brands Corp. owns a portfolio of brands of medical cannabis and recreational cannabis products. The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors in the states of Colorado, Nevada, Oklahoma, and Massachusetts. It offers cannabis infused gummy products, disposable vape pens, distillate droppers, and shatter and wax concentrate products under the CannAmerica brand. The company is headquartered in Vancouver, Canada.

Cannamerica Brands Corp

595 Howe Street, Vancouver, BC, Canada, V6C 2T5

844 484 3996
https://www.cannamericabrands.com

Key Executives

Name	Title	Year Born
Ms. Diana Anglin	Interim CFO, COO, Corp. Sec. & Director	NA
Mr. Austin Sims	Chief Science Officer & Independent Director	NA
Ms. Diana Anglin	Interim CFO, COO, Corporate Secretary & Director	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.